CIBERSAM Stanley International Mood Disorders Research Centre, Hospital Santiago Apóstol, University of the Basque Country, Vitoria, Spain.
Pharmacopsychiatry. 2010 Nov;43(7):263-70. doi: 10.1055/s-0030-1263169. Epub 2010 Sep 14.
This study aimed to identify factors associated with medication adherence in bipolar disorder (BPD) patients.
EMBLEM is a 2-year, prospective, observational study on the outcomes of BPD patients initiating or changing treatment for a manic/mixed episode. Data were collected at baseline, during the first 12 weeks of treatment (acute phase) and up to 24 months of follow-up (maintenance phase). Adherence was assessed by investigators at every visit. Repeated measures logistic regression analyses identified variables associated with adherence.
Of 1,831 patients included in the analysis, 76.6% were adherent and 23.4% were non-adherent with their BPD medication during the maintenance phase. Patients were more likely to be adherent if they had insight into their illness at week 12. Patients were less likely to be adherent if they had cannabis abuse/dependence during the acute phase, work impairment or higher CGI hallucinations/delusions at baseline
Psychotic symptoms, poor insight, cannabis abuse/dependence and work impairment are negatively related to medication adherence during maintenance therapy of bipolar disorder. Patients with these characteristics may need a different therapeutic approach.
本研究旨在确定与双相情感障碍(BPD)患者药物依从性相关的因素。
EMBLEM 是一项为期 2 年的前瞻性观察性研究,旨在研究 BPD 患者在开始或改变治疗躁狂/混合发作时的结局。数据在基线、治疗的前 12 周(急性期)和 24 个月的随访(维持期)时收集。每次就诊时由研究者评估依从性。重复测量逻辑回归分析确定与依从性相关的变量。
在纳入分析的 1831 例患者中,76.6%在维持期依从 BPD 药物,23.4%不依从。在第 12 周时患者对自己的疾病有认识时,更有可能依从。在急性期有大麻滥用/依赖、工作受损或基线时 CGI 幻觉/妄想较高的患者,更不可能依从。
精神病症状、洞察力差、大麻滥用/依赖和工作受损与双相情感障碍维持治疗期间的药物依从性呈负相关。具有这些特征的患者可能需要不同的治疗方法。